Fusion Pharmaceuticals Inc. Share-based Payment Arrangement, Expense
Fusion Pharmaceuticals Inc. reported Share-based Payment Arrangement, Expense of $4.52 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2024-05-07
- Fusion Pharmaceuticals Inc. share-based payment arrangement, expense for the quarter ending 2024-03-31 was $4.52M, a 43.44% increase year-over-year.
- Fusion Pharmaceuticals Inc. share-based payment arrangement, expense for the quarter ending 2023-12-31 was $3.25M, a 17.17% increase year-over-year.
- Fusion Pharmaceuticals Inc. share-based payment arrangement, expense for the quarter ending 2023-09-30 was $2.99M, a 11.01% increase year-over-year.
- Fusion Pharmaceuticals Inc. share-based payment arrangement, expense for the quarter ending 2023-06-30 was $3.05M, a 11.33% increase year-over-year.
- Fusion Pharmaceuticals Inc. share-based payment arrangement, expense for fiscal 2023 was $12.44M, a 14.75% increase from fiscal 2022.
- Fusion Pharmaceuticals Inc. share-based payment arrangement, expense for fiscal 2022 was $10.84M, a 26.05% increase from fiscal 2021.
- Fusion Pharmaceuticals Inc. share-based payment arrangement, expense for fiscal 2021 was $8.60M, a 155.43% increase from fiscal 2020.
- Fusion Pharmaceuticals Inc. share-based payment arrangement, expense for fiscal 2020 was $3.37M, a 444.98% increase from fiscal 2019.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $4.52M 10-Q · filed 2024-05-07 | $7.77M derived: sum of 2 quarters · filed 2024-05-07 | $10.77M derived: sum of 3 quarters · filed 2024-05-07 | $13.81M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-31 | $3.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $6.25M derived: sum of 2 quarters · filed 2024-03-20 | $9.29M derived: sum of 3 quarters · filed 2024-03-20 | $12.44M 10-K · filed 2024-03-20 |
| 2023-09-30 | $2.99M 10-Q · filed 2023-11-07 | $6.04M derived: sum of 2 quarters · filed 2023-11-07 | $9.19M 10-Q · filed 2023-11-07 | $11.97M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-06-30 | $3.05M 10-Q · filed 2023-08-08 | $6.20M 10-Q · filed 2023-08-08 | $8.97M derived: sum of 3 quarters · filed 2024-05-07 | $11.67M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-03-31 | $3.15M 10-Q · filed 2024-05-07 | $5.93M derived: sum of 2 quarters · filed 2024-05-07 | $8.62M derived: sum of 3 quarters · filed 2024-05-07 | $11.36M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $5.47M derived: sum of 2 quarters · filed 2024-03-20 | $8.21M derived: sum of 3 quarters · filed 2024-03-20 | $10.84M 10-K · filed 2024-03-20 |
| 2022-09-30 | $2.70M 10-Q · filed 2023-11-07 | $5.43M derived: sum of 2 quarters · filed 2023-11-07 | $8.07M 10-Q · filed 2023-11-07 | $10.43M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $2.74M 10-Q · filed 2023-08-08 | $5.37M 10-Q · filed 2023-08-08 | $7.74M derived: sum of 3 quarters · filed 2023-08-08 | $10.11M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $2.63M 10-Q · filed 2023-05-11 | $5.00M derived: sum of 2 quarters · filed 2023-05-11 | $7.37M derived: sum of 3 quarters · filed 2023-05-11 | $9.52M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $4.74M derived: sum of 2 quarters · filed 2023-03-16 | $6.88M derived: sum of 3 quarters · filed 2023-03-16 | $8.60M 10-K · filed 2023-03-16 |
| 2021-09-30 | $2.37M 10-Q · filed 2022-11-08 | $4.52M derived: sum of 2 quarters · filed 2022-11-08 | $6.24M 10-Q · filed 2022-11-08 | $7.58M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $2.15M 10-Q · filed 2022-08-09 | $3.86M 10-Q · filed 2022-08-09 | $5.21M derived: sum of 3 quarters · filed 2022-08-09 | $6.45M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $1.72M 10-Q · filed 2022-05-10 | $3.06M derived: sum of 2 quarters · filed 2022-05-10 | $4.30M derived: sum of 3 quarters · filed 2022-05-10 | $4.73M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $2.58M derived: sum of 2 quarters · filed 2022-03-17 | $3.01M derived: sum of 3 quarters · filed 2022-03-17 | $3.37M 10-K · filed 2022-03-17 |
| 2020-09-30 | $1.24M 10-Q · filed 2021-11-09 | $1.67M derived: sum of 2 quarters · filed 2021-11-09 | $2.02M 10-Q · filed 2021-11-09 | $2.31M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $426.00K 10-Q · filed 2021-08-10 | $784.00K 10-Q · filed 2021-08-10 | $1.07M derived: sum of 3 quarters · filed 2021-08-10 | $1.21M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $358.00K 10-Q · filed 2021-05-11 | $648.00K derived: sum of 2 quarters · filed 2021-05-11 | $786.00K derived: sum of 3 quarters · filed 2021-05-11 | $874.00K derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $290.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $428.00K derived: sum of 2 quarters · filed 2021-03-25 | $516.00K derived: sum of 3 quarters · filed 2021-03-25 | $618.00K 10-K · filed 2021-03-25 |
| 2019-09-30 | $138.00K 10-Q · filed 2020-11-10 | $226.00K derived: sum of 2 quarters · filed 2020-11-10 | $328.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $88.00K 10-Q · filed 2020-08-11 | $190.00K 10-Q · filed 2020-08-11 |